NCM
CRBP icon

Northstar Capital Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Northstar Capital Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$4K Hold
28
– – ﹤0.01% 88
2019
Q2 		$6K Hold
28
– – 0.01% 87
2019
Q1 		$6K Buy
+28
New +$6.17K 0.01% 88

Other funds holding CRBP

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northstar Capital Management's CRBP Position: Q3 2019 in Review

Northstar Capital Management held its Corbus Pharmaceuticals (CRBP) position steady in Q3 2019 at 28 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #88.

Northstar Capital Management first reported a position in CRBP in Q1 2019 and has held it in 3 quarters since. The position peaked at $6K in Q2 2019. 103 funds tracked by Wall St. Rank hold CRBP as of Q3 2019.

  • Northstar Capital Management held 28 shares of Corbus Pharmaceuticals worth $4K as of Q3 2019.
  • Northstar Capital Management left its Corbus Pharmaceuticals share count unchanged in Q3 2019.
  • Corbus Pharmaceuticals made up ﹤0.01% of Northstar Capital Management's portfolio in Q3 2019, its #88 holding.
  • Northstar Capital Management first reported a position in Corbus Pharmaceuticals in Q1 2019 and has held it in 3 quarters since.
  • Northstar Capital Management's Corbus Pharmaceuticals position peaked at $6K in Q2 2019.
  • 103 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2019.

Based on Northstar Capital Management's 13F filing for Q3 2019, filed 7 Nov 2019.